-
IntroducedFeb 27, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
Individualized Investigational Treatments ; Authorizes certain actions by eligible facilities, manufacturers operating within eligible facilities, & eligible patients relating to individualized investigational treatments; authorizes health plans, third-party administrators, & governmental agencies to provide coverage for cost of individualized investigational drug, biological product, or device, or cost of certain services; limits liability; prohibits licensing boards, disciplinary subcommittees, & entities responsible for Medicare certification from taking certain actions against health care provider's license; prohibits certain persons from blocking or attempting to block eligible patient's access to individualized investigational drug, biological product, or device; provides construction.
Summary/Bill Text
Comments on HB 1333
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 27, 2025 | House
- Filed
Bill Texts
Documents